Results 151 to 160 of about 44,475 (230)

CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management. [PDF]

Int J Nanomedicine
Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A, Ullah K, Xiangxiang X, Chen G, Diao Y.   +9 more
europepmc   +1 more source

Radiation-activated astrocytes promote tumor progression through CXCL12 secretion and induce resistance to anti-PD-1 immunotherapy. [PDF]

Transl Cancer Res
Li X, Wei H, Zhu Y, Feng P, Wang J, Yuan G, Pan Y.   +6 more
europepmc   +1 more source

CXCL12 Promotes Peripheral Nerve Injury Repair by Inhibiting the Ferroptosis-Inflammation Axis via the ERK/Nrf2 Pathway. [PDF]

Inflammation
Yuan Y, Jiang Y, Du S, Yuan G, Yang Z, Wang P.   +5 more
europepmc   +1 more source

Signaling pathway mechanisms in pancreatic ductal adenocarcinoma tumor microenvironment and emerging targeting strategies for improved prognosis. [PDF]

Oncol Rev
Akinsipe T, Odewumi CO, Latinwo L, Aghimien OO, Musa MA, Igbinoba PO, Simons AL, Aghimien MO.   +7 more
europepmc   +1 more source

A RANKL⁺/CXCR4⁺ B cell population accumulates in bone marrow and causes age-related osteoporosis in mice. [PDF]

Bone Res
Li J, Fan J, Yao Z, Jiao H, Duan R, Sanders JO, Mesfin A, Xing L, Boyce BF.   +8 more
europepmc   +1 more source

CXCL12/ZNF503/GATA3/MMP1 axis promotes tumor progression and metastasis of triple-negative breast cancer. [PDF]

Breast Cancer Res
Liu S, Liu A, Zhang L, Li J, Cao X, Yu P, Han Y, Liu J.   +7 more
europepmc   +1 more source

Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4⁺ neutrophils and S100A8⁺ monocytes. [PDF]

J Immunother Cancer
Zeng P, Li HF, Shu WB, Zhang J, Zhao TC, Hu JW, Wang JF, Wang C, Lu QY, Yang JH, An YL, Chen R.   +11 more
europepmc   +1 more source

CXCL12-Abundant Reticular Cell [PDF]

, 2020
openaire   +1 more source

Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective. [PDF]

Metabolites
Matwiejuk M, Myśliwiec H, Mikłosz A, Chabowski A, Flisiak I.   +4 more
europepmc   +1 more source